(Q28343297)

English

In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

scientific article (publication date: May 1999)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole (English)

0 references

1 reference

J M Torres-Rodríguez

1

0 references

R Mendez

series ordinal

2

0 references

O López-Jodra

series ordinal

3

0 references

Y Morera

series ordinal

4

0 references

M Espasa

series ordinal

5

0 references

T Jimenez

series ordinal

6

0 references

C Lagunas

series ordinal

7

0 references

language of work or name

English

0 references

publication date

May 1999

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

43

0 references

issue

5

0 references

page(s)

1258-9

0 references

cites work

Resistance of yeasts to azole-derivative antifungals

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89253

retrieved

29 September 2017

Improved medium for fluconazole susceptibility testing of Candida albicans

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89253

retrieved

29 September 2017

Resistance of Candida species to fluconazole

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89253

retrieved

29 September 2017

Epidemiology of candidiasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89253

retrieved

29 September 2017

Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89253

retrieved

27 November 2018

Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89253

retrieved

27 November 2018

Identifiers

0 references

0 references

(Q28343297)

In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)